AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.12B |
| 2 |
NVIDIA
NVDA
|
+$501M |
| 3 |
Sherwin-Williams
SHW
|
+$345M |
| 4 |
Veralto
VLTO
|
+$342M |
| 5 |
lululemon athletica
LULU
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$820M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$470M |
| 3 |
Zoetis
ZTS
|
+$341M |
| 4 |
PTC
PTC
|
+$288M |
| 5 |
Tyler Technologies
TYL
|
+$260M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.64% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAIN
3126
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $51.1K | ﹤0.01% |
42,580
| – | – |
|
3127
CorMedix
CRMD
$596M
| $50.8K | ﹤0.01% |
13,500
| – | – |
|
3128
Acacia Research
ACTG
$447M
| $49.4K | ﹤0.01% |
+12,600
| New | +$46.6K |
|
3129
Nautilus Biotechnolgy
NAUT
$211M
| $49.2K | ﹤0.01% |
16,470
-110
| -0.7% | -$315 |
|
3130
Information Services Group
III
$192M
| $48.9K | ﹤0.01% |
+10,390
| New | +$45.4K |
|
|
ASRT
3131
DELISTED
Assertio
ASRT
| $48.5K | ﹤0.01% |
3,021
| – | – |
|
3132
Purple Innovation
PRPL
$35.8M
| $47.8K | ﹤0.01% |
1,856
-322
| -15% | -$8.26K |
|
3133
CXApp
CXAI
$12.1M
| $46K | ﹤0.01% |
35,630
+4,070
| +13% | +$5.79K |
|
3134
Cadiz
CDZI
$259M
| $45.6K | ﹤0.01% |
16,290
-3,190
| -16% | -$9.62K |
|
3135
MarketWise
MKTW
$54.4M
| $44.7K | ﹤0.01% |
819
+149
| +22% | +$7.29K |
|
3136
Accuray
ARAY
$26.8M
| $43.9K | ﹤0.01% |
15,520
| – | – |
|
|
KLRS
3137
Kalaris Therapeutics
KLRS
$85.2M
| $43.8K | ﹤0.01% |
2,801
-272
| -9% | -$10.7K |
|
|
NOTE
3138
DELISTED
FiscalNote
NOTE
| $43.2K | ﹤0.01% |
3,155
| – | – |
|
3139
Urban One Class A
UONE
$22.7M
| $42.6K | ﹤0.01% |
1,058
-25
| -2% | -$1.17K |
|
3140
Veritone
VERI
$100M
| $42.6K | ﹤0.01% |
23,530
+3,550
| +18% | +$7.91K |
|
|
SRTA
3141
Strata Critical Medical Inc
SRTA
$445M
| $42.1K | ﹤0.01% |
11,940
| – | – |
|
3142
Protalix BioTherapeutics
PLX
$193M
| $41.7K | ﹤0.01% |
23,400
| – | – |
|
|
EVA
3143
DELISTED
Enviva Inc.
EVA
| $41.5K | ﹤0.01% |
41,680
-12,420
| -23% | -$34.5K |
|
|
NXDR
3144
Nextdoor Holdings
NXDR
$870M
| $41K | ﹤0.01% |
21,700
| – | – |
|
3145
Babcock & Wilcox
BW
$1.4B
| $40.1K | ﹤0.01% |
27,470
| – | – |
|
|
MOND
3146
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $39.2K | ﹤0.01% |
14,190
-640
| -4% | -$2.28K |
|
|
DADA
3147
DELISTED
Dada Nexus
DADA
| $38.9K | ﹤0.01% |
11,727
| – | – |
|
3148
Century Therapeutics
IPSC
$377M
| $38.4K | ﹤0.01% |
11,580
-1,100
| -9% | -$2K |
|
3149
X4 Pharmaceuticals
XFOR
$372M
| $38.3K | ﹤0.01% |
1,523
| – | – |
|
3150
Omeros
OMER
$821M
| $38.3K | ﹤0.01% |
11,700
| – | – |
|
Similar funds
AllianceBernstein's Q4 2023 Portfolio in Review
As of Q4 2023, AllianceBernstein held 3,257 positions worth $260B, up 11% from $235B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 4.6%. AllianceBernstein opened 73 new positions and exited 76, leaving the 3,257-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2023 buy was Veralto: 4,581,649 shares worth $377M.
- AllianceBernstein added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.12B increase.
- AllianceBernstein's biggest Q4 2023 reduction was Microsoft, cutting an estimated $820M.
- AllianceBernstein fully exited Activision Blizzard in Q4 2023, selling an estimated $125M.
- AllianceBernstein's ten largest holdings make up 25% of its $260B portfolio in Q4 2023.
- AllianceBernstein opened 73 new positions and closed 76 in Q4 2023.
- AllianceBernstein's portfolio value rose 11% quarter-over-quarter to $260B.
Based on AllianceBernstein's 13F filing for Q4 2023, filed 14 Feb 2024.